CIDARA THERAPEUTICS, INC. Operating Lease Right-of-Use Assets
CIDARA THERAPEUTICS, INC. had Operating Lease Right-of-Use Assets of $1.79 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-11-06
- 2025-09-30: Operating Lease, Right-of-Use Asset $1.79M.
- 2025-06-30: Operating Lease, Right-of-Use Asset $2.12M.
- 2025-03-31: Operating Lease, Right-of-Use Asset $2.44M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $2.74M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2025-09-30 | $1.79M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $2.12M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $2.44M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $2.74M 10-Q · filed 2025-11-06 | |
| 2024-09-30 | $3.04M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $3.32M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $3.60M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $3.79M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $4.05M 10-K · filed 2024-04-22 | $4.13M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $4.31M 10-K · filed 2024-04-22 | $4.39M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $836.00K 10-K · filed 2024-04-22 | $917.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.10M 10-K · filed 2024-04-22 | $1.21M 10-K · filed 2023-03-23 |
| 2022-09-30 | $1.35M 10-K · filed 2024-04-22 | $1.49M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.60M 10-K · filed 2024-04-22 | $1.76M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.85M 10-K · filed 2024-04-22 | $2.03M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $2.29M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $2.54M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $446.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $663.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $868.00K 10-K · filed 2022-03-07 | |
| 2020-09-30 | $1.06M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.26M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.45M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.63M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.81M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.98M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $2.13M 10-Q · filed 2019-05-09 |